Published in J Virol on June 06, 2007
Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol (2011) 1.43
Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J Neurosci Res (2008) 1.09
Retracted Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats. J Neuroinflammation (2011) 1.06
Increased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease. Virology (2009) 0.96
A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120. J Neuroimmune Pharmacol (2011) 0.91
The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun (2015) 0.87
Ethanol concentration-dependent alterations in gene expression during acute binge drinking in the HIV-1 transgenic rat. Alcohol Clin Exp Res (2013) 0.86
Age- and ethanol concentration-dependent effects of acute binge drinking in the HIV-1 transgenic rat. Alcohol Clin Exp Res (2012) 0.84
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. Eur J Pharmacol (2012) 0.83
Endotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat. J Neuroinflammation (2012) 0.83
HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging. PLoS One (2014) 0.79
Latest trends in drugs of abuse - HIV infection and neuroAIDS. Future Virol (2013) 0.78
Morphine-induced conditioned place preference and associated behavioural plasticity in HIV-1 transgenic rats. Int J Clin Exp Med (2012) 0.78
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci U S A (2002) 17.22
Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther (2003) 2.29
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A (2001) 2.28
The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol (2003) 1.73
Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev (2003) 1.71
Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology (2003) 1.51
Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. Curr Pharm Des (2005) 1.43
Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther (2003) 1.40
Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull (2001) 1.38
Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol (2000) 1.31
Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS). J Leukoc Biol (1988) 1.29
Chronic morphine accelerates the progression of lipopolysaccharide-induced sepsis to septic shock. J Neuroimmunol (2004) 1.29
Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med (2002) 1.23
Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem (2001) 1.22
Morphine induces sepsis in mice. J Infect Dis (1997) 1.19
Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol (2006) 1.18
Molecular targets of opiate drug abuse in neuroAIDS. Neurotox Res (2005) 1.16
HIV-1 transgenic rats develop T cell abnormalities. Virology (2004) 1.14
Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacol Ther (2002) 1.14
HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS). Pain (2004) 1.13
Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects. DNA Cell Biol (2005) 1.11
Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART. Bull Math Biol (2005) 1.10
Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry. J Infect Dis (2002) 1.08
A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. Kidney Int (2003) 1.08
Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model. J Neuroimmunol (2004) 1.02
Differential expression of cytokines in the brain and serum during endotoxin tolerance. J Neuroimmunol (2005) 1.01
Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6. Mol Pharmacol (2004) 0.98
Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems. J Leukoc Biol (2005) 0.96
Failure to eradicate HIV despite fully successful HAART initiated in the first days of life. J Pediatr (2006) 0.96
HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection. Clin Exp Immunol (1994) 0.94
Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12. J Neuroimmunol (2005) 0.92
Interleukin-1 induces the expression of mu opioid receptors in endothelial cells. Immunopharmacology (1998) 0.92
Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun (1995) 0.92
Expression of functional mu-opioid receptors during T cell development. J Neuroimmunol (2001) 0.91
Immunomodulatory effects of the HIV-1 gp120 protein on antigen presenting cells: implications for AIDS pathogenesis. Immunobiology (2004) 0.89
Morphine withdrawal lowers host defense to enteric bacteria: spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection. Infect Immun (2006) 0.89
Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response. Immunopharmacology (2000) 0.89
HIV-1 gp120 up-regulation of the mu opioid receptor in TPA-differentiated HL-60 cells. Int Immunopharmacol (2006) 0.87
Monocytes/macrophages in HIV infection and tuberculosis. J Biol Regul Homeost Agents (2001) 0.86
Cytokine reversal of morphine-induced suppression of the antibody response. J Pharmacol Exp Ther (1993) 0.85
Opioid receptor expression and function. J Neuroimmunol (2004) 0.85
Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice. J Neuroimmunol (2001) 0.82
Long-term methadone treatment: effect on CD4+ lymphocyte counts and HIV-1 plasma RNA level in patients with HIV infection. Eur J Pain (2001) 0.80
Expression and regulation of the mu opioid peptide receptor in TPA-differentiated HL-60 promyelocytic leukemia cells. Int Immunopharmacol (2006) 0.79
A role for serine proteases in mediating phorbol ester-induced differentiation of HL-60 cells. Exp Cell Res (2000) 0.78
Opioid receptors on white blood cells: effect of HIV infection and methadone treatment. Pain (2002) 0.78
Prediction of death in the SMNΔ7 mouse model of spinal muscular atrophy: insight into disease stage and progression. J Neurosci Methods (2012) 0.79